4PR-87140-58636
3 vaccinations
5 coded responses
21 check-ins
5 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 030 / NH
- Registered
- 2021-01-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-22
Dose 1 — Moderna
-
2021-01-26
Registered in v-safe
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-02-05
- 2021-02-19
-
2021-02-20
Dose 2 — Moderna
-
2021-02-21
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workFree text: dizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body achesAdult check-in
-
2021-02-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-03-06
-
2021-03-13
Survey response — day 21, dose 2MedDRA: Headache, Pain, Respiratory tract congestion, Rhinorrhoea — Feeling: FairFree text: just feeling mild achy all over, headaches runny nose, chest congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-20
Survey response — day 28, dose 2MedDRA: Coordination abnormal, Dysarthria, Headache, Nausea, Vomiting — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: uncoordinated, nausea, vomiting, headache, slurred speechMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-20
Report sent to call center — day 28, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-27
- 2021-04-03
- 2021-05-22
- 2021-08-21
-
2021-12-15
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2021-12-17
Dose 3 — Moderna
-
2022-02-20
Survey response — 12 months, dose 2MedDRA: Diplopia, Dysarthria, Headache, Pain, Sinusitis — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: sinus infections, body aches, HA'S, slurred speech, double visionMedDRA releases: 2024-11 · check-in free text available
-
2022-02-20
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-02-21
-
2022-12-17
Survey response — 12 months, dose 3MedDRA: Ehlers-Danlos syndrome, Hypermobility syndrome, Medical counselling, Migraine, Office visit, Vertigo — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Migraines, vertigo. Was Dx'd with Hypermobility by rheumatologist summer 2022. But D/T these 2 sx's persisted >2 wks then saw chiropractor that discovered/clairfied i have: hEDS (hypermobility Ehler's Danlos Syndrome) = cause of my sx's · Healthcare visit (other): Called drs; then saw chiropractorMedDRA releases: 2024-11 · check-in free text available
-
2022-12-17
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2022-12-19
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-12-19
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-22 | Moderna | |
| 2 | 2021-02-20 | Moderna | |
| 3 | 2021-12-17 | Moderna | No |
Call center
3 call center cases
3 successful
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): dizziness
Release 5 — day 21, dose 2
Symptoms: just feeling mild achy all over, headaches runny nose, chest congestion
Release 6 — day 28, dose 2
Symptoms: uncoordinated, nausea, vomiting, headache, slurred speech
Release 11 — 12 months, dose 2
Symptoms: sinus infections, body aches, HA'S, slurred speech, double vision
Release 12 — 12 months, dose 3
Symptoms: Migraines, vertigo. Was Dx'd with Hypermobility by rheumatologist summer 2022. But D/T these 2 sx's persisted >2 wks then saw chiropractor that discovered/clairfied i have: hEDS (hypermobility Ehler's Danlos Syndrome) = cause of my sx's
Healthcare visit (other): Called drs; then saw chiropractor
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| HCVO | Office visit | · | · | ✓ |
| SD | Coordination abnormal | ✓ | ✓ | ✓ |
| SD | Diplopia | · | · | ✓ |
| SD | Dysarthria | ✓ | ✓ | ✓ |
| SD | Ehlers-Danlos syndrome | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hypermobility syndrome | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Vertigo | · | · | ✓ |
| SD | Vomiting | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release